These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21514823)

  • 1. Design, synthesis, and biological activity of novel Magmas inhibitors.
    Jubinsky PT; Short MK; Ghanem M; Das BC
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3479-82. PubMed ID: 21514823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design strategies to target crystallographic waters applied to the Hsp90 molecular chaperone.
    Kung PP; Sinnema PJ; Richardson P; Hickey MJ; Gajiwala KS; Wang F; Huang B; McClellan G; Wang J; Maegley K; Bergqvist S; Mehta PP; Kania R
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3557-62. PubMed ID: 21612924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of small-molecule inhibitors for β-catenin/T-cell factor protein-protein interactions by bioisostere replacement.
    Yu B; Huang Z; Zhang M; Dillard DR; Ji H
    ACS Chem Biol; 2013 Mar; 8(3):524-9. PubMed ID: 23272635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of purin-2-yl and purin-6-yl-aminoglucitols as C-nucleosidic ATP mimics and biological evaluation as FGFR3 inhibitors.
    Tak-Tak L; Barbault F; Maurel F; Busca P; Le Merrer Y
    Eur J Med Chem; 2011 Apr; 46(4):1254-62. PubMed ID: 21334122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent small molecule Hedgehog agonists induce VEGF expression in vitro.
    Seifert K; Büttner A; Rigol S; Eilert N; Wandel E; Giannis A
    Bioorg Med Chem; 2012 Nov; 20(21):6465-81. PubMed ID: 22985958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.
    Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of small molecular polyphenols as entry inhibitors against H(5)N(1).
    Yang J; Yang JX; Zhang F; Chen G; Pan W; Yu R; Wu S; Tien P
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2680-4. PubMed ID: 24803363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magmas inhibition as a potential treatment strategy in malignant glioma.
    Di K; Lomeli N; Bota DA; Das BC
    J Neurooncol; 2019 Jan; 141(2):267-276. PubMed ID: 30414099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magmas gene structure and evolution.
    Peng J; Huang CH; Short MK; Jubinsky PT
    In Silico Biol; 2005; 5(3):251-63. PubMed ID: 15984936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design, analysis, and potential utility of GM-CSF antagonists.
    Monfardini C; Kieber-Emmons T; VonFeldt JM; Godillot AP; Voet D; Weiner DB; Williams WV
    Proc Assoc Am Physicians; 1996 Nov; 108(6):420-31. PubMed ID: 8956365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy.
    Liu Z; Li B; Li X; Zhang L; Lai L
    J Chem Inf Model; 2011 Feb; 51(2):326-34. PubMed ID: 21284404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
    Wodicka LM; Ciceri P; Davis MI; Hunt JP; Floyd M; Salerno S; Hua XH; Ford JM; Armstrong RC; Zarrinkar PP; Treiber DK
    Chem Biol; 2010 Nov; 17(11):1241-9. PubMed ID: 21095574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery.
    Erlanson DA; Arndt JW; Cancilla MT; Cao K; Elling RA; English N; Friedman J; Hansen SK; Hession C; Joseph I; Kumaravel G; Lee WC; Lind KE; McDowell RS; Miatkowski K; Nguyen C; Nguyen TB; Park S; Pathan N; Penny DM; Romanowski MJ; Scott D; Silvian L; Simmons RL; Tangonan BT; Yang W; Sun L
    Bioorg Med Chem Lett; 2011 May; 21(10):3078-83. PubMed ID: 21459573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.
    Mori M; Vignaroli G; Cau Y; Dinić J; Hill R; Rossi M; Colecchia D; Pešić M; Link W; Chiariello M; Ottmann C; Botta M
    ChemMedChem; 2014 May; 9(5):973-83. PubMed ID: 24715717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compounds binding to the S2-S3 pockets of thrombin.
    Nilsson M; Hämäläinen M; Ivarsson M; Gottfries J; Xue Y; Hansson S; Isaksson R; Fex T
    J Med Chem; 2009 May; 52(9):2708-15. PubMed ID: 19371038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial synthetic receptors as regulators of protein activity.
    Dutt S; Wilch C; Schrader T
    Chem Commun (Camb); 2011 May; 47(19):5376-83. PubMed ID: 21394349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating high-content screening and ligand-target prediction to identify mechanism of action.
    Young DW; Bender A; Hoyt J; McWhinnie E; Chirn GW; Tao CY; Tallarico JA; Labow M; Jenkins JL; Mitchison TJ; Feng Y
    Nat Chem Biol; 2008 Jan; 4(1):59-68. PubMed ID: 18066055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity-oriented synthesis; a spectrum of approaches and results.
    Spandl RJ; Bender A; Spring DR
    Org Biomol Chem; 2008 Apr; 6(7):1149-58. PubMed ID: 18362950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.